In this guide
Health conditions Golden Retrievers are prone to
Goldens carry two distinct risk categories. Orthopaedic problems, which they share with other large retrievers, and cancer, where their incidence is markedly higher than the general dog population. The second is what makes annual limit headroom matter more for this breed than almost any other.
| Condition | Typical cost | Notes |
|---|---|---|
| Haemangiosarcoma | $8,000 to $15,000 | Aggressive, notably elevated in the breed |
| Lymphoma | $6,000 to $12,000 | Chemotherapy over several months |
| Mast cell tumours | $3,000 to $8,000 | Often recurrent, multiple surgeries |
| Hip dysplasia | $4,000 to $9,000 | Common in the breed |
| Cruciate ligament rupture | $3,000 to $7,000 | Large breed, elevated risk |
| Hypothyroidism | $400 to $900 per year | Lifelong medication once diagnosed |
| Atopic dermatitis | $800 to $2,500 per year | Chronic skin allergy |
What insurance costs for a Golden Retriever
Golden Retriever premiums sit above the Australian dog average, driven by both claim frequency and claim value. Insurers price the cancer risk in, and it shows most clearly in the older age brackets.
| Age | Typical monthly premium |
|---|---|
| Puppy, under 1 year | $60 to $85 |
| 2 to 4 years | $85 to $125 |
| 5 to 7 years | $125 to $175 |
| 8 years and over | $175 to $250 |
Policy terms that affect claims for this breed
Three parts of a PDS have more bearing on what a Golden Retriever claim pays than the headline premium does. What follows describes how those terms operate. It is not a recommendation to buy or hold any particular policy.
1. How sub-limits on cancer treatment and specialist referral work
Two sub-limits have particular effect for this breed. Specialist referral, because oncology is almost always a referral, and orthopaedic, because cruciate and hip claims are common. A $1,500 specialist consultation sub-limit is reached during a cancer workup involving imaging, biopsy and oncologist review.
2. How waiting periods apply
The standard 30 day illness wait applies to cancer. Orthopaedic conditions carry six months. Cancer can develop at any age in this breed, so incidence is not concentrated in later life in the way some breed risks are.
3. How exclusions are defined
Treatment of chemotherapy, radiation and specialist oncology varies between policies. Some cover surgery while capping or excluding ongoing oncology. Whether the annual limit resets each policy year also varies, and cancer treatment frequently spans two policy periods.
How three providers compare
Policy features relevant to the conditions described above, as published by each insurer. This is a factual comparison, not a ranking or a recommendation.
| Provider | Relevant policy feature | Annual limit |
|---|---|---|
| Pet Insurance Australia | Highest annual limit of the three | Up to $25,000 |
| Knose | No sub-limits, including on specialist referral | Up to $20,000 |
| Bow Wow Meow | Cancer treatment terms set out explicitly in the PDS | Up to $15,000 |
Common questions
Summary
Golden Retrievers carry an elevated cancer incidence alongside the orthopaedic risks common to large retrievers. Cancer treatment is typically prolonged, referral-heavy and spread across policy years, so annual limit headroom, specialist referral sub-limits and whether limits reset annually each affect the outcome of a claim more than the premium does.
Condition costs are indicative ranges compiled from Australian veterinary pricing sources. Premium figures are published averages, sourced on each page. Policy features are as published by each insurer and current at July 2026; verify against the current PDS before relying on them.